TB-SM-01

N/A

Report date: 2023/12/12 16:58:02

NME

Base Information

Drug NameTB-SM-01

Drug Alias NameTB-SM-01

ClassificationSmall molecules

Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitors

TargetsExtracellular-signal-regulated kinase1

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTheragen Bio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A